Global Chronic Diseases Management Market

Chronic Diseases Management Comprehensive Study by Application (Ambulatory Care Centers, Hospitals and Physician Groups, Diagnostic Centers, Home Healthcare Agencies and Nursing Homes, Others), Disease Type (Arthritis, Cardiovascular Disease, Cancer, Diabetes) Players and Region - Global Market Outlook to 2028

Chronic Diseases Management Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Chronic diseases are long-lasting conditions which can usually can be controlled but not cured. Chronic diseases tend to develop more common with age. Some of the chronic diseases comprise of heart attacks and stroke, cancer such as breast cancer, colon cancer, diabetes, epilepsy and seizures, obesity, asthma, stroke and oral health problems. and Chronic disease management includes a defined set of interventions mostly aimed at providing high-quality healthcare and a better quality of life to patients. Chronic disease management services comprise a variety of services such as multidisciplinary care, guidelines for the self-management of the chronic disease condition and guidance for healthy behavioral change to increase awareness about various diseases.This growth is primarily driven by Growing incidence of chronic diseases .

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2022-2028
Volume UnitN
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Health Care Services sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as TriZetto Corporation (United States), Phytel Inc. (United States), Pegasystems Inc. (United States), Siemens Healthcare Private Limited (India), AxisPoint Health (United States), Wellcentive, Inc. (United States), Medecision, Inc. (United States), i2i Systems, Inc. (United States), HealthSmart Holdings, Inc. (United States), Allscripts Healthcare Solutions, Inc. (United States), Epic Corporation Inc. (United States), Harmony Information Systems, Inc. (United States) and Infosys Limited (India), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In 2021, Royal Philips and Pegasystems Inc. announced a partnership to help managed care providers and accountable care organizations better harness connected devices and health data to tailor care and enhance health outcomes.
Existing players are strengthening their foothold in the industry through various activities such as collaborations, mergers and acquisition, investments and new service launches as their preferred strategies. Key players are exploring new geographies through expansions and acquisitions across the globe to gain competitive advantage through combined synergies.

Influencing Trend:
Growth in the medical tourism sector

Market Growth Drivers:
Growing incidence of chronic diseases, Increasing awareness regarding the healthcare management and Progress in healthcare IT

Challenges:
Inadequate patient engagement

Restraints:
High investment required for the infrastructure

Opportunities:
Increasing investment in Research and development and Increasing healthcare expenditure in emerging economies

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Chronic Diseases Management Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Chronic Diseases Management Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Chronic Diseases Management players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Chronic Diseases Management Study Sheds Light on
— The Chronic Diseases Management Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Chronic Diseases Management industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Chronic Diseases Management industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Application
  • Ambulatory Care Centers
  • Hospitals and Physician Groups
  • Diagnostic Centers
  • Home Healthcare Agencies and Nursing Homes
  • Others
By Disease Type
  • Arthritis
  • Cardiovascular Disease
  • Cancer
  • Diabetes

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing incidence of chronic diseases
      • 3.2.2. Increasing awareness regarding the healthcare management
      • 3.2.3. Progress in healthcare IT
    • 3.3. Market Challenges
      • 3.3.1. Inadequate patient engagement
    • 3.4. Market Trends
      • 3.4.1. Growth in the medical tourism sector
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Chronic Diseases Management, by Application, Disease Type and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Chronic Diseases Management (Value)
      • 5.2.1. Global Chronic Diseases Management by: Application (Value)
        • 5.2.1.1. Ambulatory Care Centers
        • 5.2.1.2. Hospitals and Physician Groups
        • 5.2.1.3. Diagnostic Centers
        • 5.2.1.4. Home Healthcare Agencies and Nursing Homes
        • 5.2.1.5. Others
      • 5.2.2. Global Chronic Diseases Management by: Disease Type (Value)
        • 5.2.2.1. Arthritis
        • 5.2.2.2. Cardiovascular Disease
        • 5.2.2.3. Cancer
        • 5.2.2.4. Diabetes
      • 5.2.3. Global Chronic Diseases Management Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Chronic Diseases Management: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. TriZetto Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Phytel Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Pegasystems Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Siemens Healthcare Private Limited (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. AxisPoint Health (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Wellcentive, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Medecision, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. I2i Systems, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. HealthSmart Holdings, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Allscripts Healthcare Solutions, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Epic Corporation Inc. (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Harmony Information Systems, Inc. (United States)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Infosys Limited (India)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
  • 7. Global Chronic Diseases Management Sale, by Application, Disease Type and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Chronic Diseases Management (Value)
      • 7.2.1. Global Chronic Diseases Management by: Application (Value)
        • 7.2.1.1. Ambulatory Care Centers
        • 7.2.1.2. Hospitals and Physician Groups
        • 7.2.1.3. Diagnostic Centers
        • 7.2.1.4. Home Healthcare Agencies and Nursing Homes
        • 7.2.1.5. Others
      • 7.2.2. Global Chronic Diseases Management by: Disease Type (Value)
        • 7.2.2.1. Arthritis
        • 7.2.2.2. Cardiovascular Disease
        • 7.2.2.3. Cancer
        • 7.2.2.4. Diabetes
      • 7.2.3. Global Chronic Diseases Management Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Chronic Diseases Management: by Application(USD Million)
  • Table 2. Chronic Diseases Management Ambulatory Care Centers , by Region USD Million (2017-2022)
  • Table 3. Chronic Diseases Management Hospitals and Physician Groups , by Region USD Million (2017-2022)
  • Table 4. Chronic Diseases Management Diagnostic Centers , by Region USD Million (2017-2022)
  • Table 5. Chronic Diseases Management Home Healthcare Agencies and Nursing Homes , by Region USD Million (2017-2022)
  • Table 6. Chronic Diseases Management Others , by Region USD Million (2017-2022)
  • Table 7. Chronic Diseases Management: by Disease Type(USD Million)
  • Table 8. Chronic Diseases Management Arthritis , by Region USD Million (2017-2022)
  • Table 9. Chronic Diseases Management Cardiovascular Disease , by Region USD Million (2017-2022)
  • Table 10. Chronic Diseases Management Cancer , by Region USD Million (2017-2022)
  • Table 11. Chronic Diseases Management Diabetes , by Region USD Million (2017-2022)
  • Table 12. South America Chronic Diseases Management, by Country USD Million (2017-2022)
  • Table 13. South America Chronic Diseases Management, by Application USD Million (2017-2022)
  • Table 14. South America Chronic Diseases Management, by Disease Type USD Million (2017-2022)
  • Table 15. Brazil Chronic Diseases Management, by Application USD Million (2017-2022)
  • Table 16. Brazil Chronic Diseases Management, by Disease Type USD Million (2017-2022)
  • Table 17. Argentina Chronic Diseases Management, by Application USD Million (2017-2022)
  • Table 18. Argentina Chronic Diseases Management, by Disease Type USD Million (2017-2022)
  • Table 19. Rest of South America Chronic Diseases Management, by Application USD Million (2017-2022)
  • Table 20. Rest of South America Chronic Diseases Management, by Disease Type USD Million (2017-2022)
  • Table 21. Asia Pacific Chronic Diseases Management, by Country USD Million (2017-2022)
  • Table 22. Asia Pacific Chronic Diseases Management, by Application USD Million (2017-2022)
  • Table 23. Asia Pacific Chronic Diseases Management, by Disease Type USD Million (2017-2022)
  • Table 24. China Chronic Diseases Management, by Application USD Million (2017-2022)
  • Table 25. China Chronic Diseases Management, by Disease Type USD Million (2017-2022)
  • Table 26. Japan Chronic Diseases Management, by Application USD Million (2017-2022)
  • Table 27. Japan Chronic Diseases Management, by Disease Type USD Million (2017-2022)
  • Table 28. India Chronic Diseases Management, by Application USD Million (2017-2022)
  • Table 29. India Chronic Diseases Management, by Disease Type USD Million (2017-2022)
  • Table 30. South Korea Chronic Diseases Management, by Application USD Million (2017-2022)
  • Table 31. South Korea Chronic Diseases Management, by Disease Type USD Million (2017-2022)
  • Table 32. Taiwan Chronic Diseases Management, by Application USD Million (2017-2022)
  • Table 33. Taiwan Chronic Diseases Management, by Disease Type USD Million (2017-2022)
  • Table 34. Australia Chronic Diseases Management, by Application USD Million (2017-2022)
  • Table 35. Australia Chronic Diseases Management, by Disease Type USD Million (2017-2022)
  • Table 36. Rest of Asia-Pacific Chronic Diseases Management, by Application USD Million (2017-2022)
  • Table 37. Rest of Asia-Pacific Chronic Diseases Management, by Disease Type USD Million (2017-2022)
  • Table 38. Europe Chronic Diseases Management, by Country USD Million (2017-2022)
  • Table 39. Europe Chronic Diseases Management, by Application USD Million (2017-2022)
  • Table 40. Europe Chronic Diseases Management, by Disease Type USD Million (2017-2022)
  • Table 41. Germany Chronic Diseases Management, by Application USD Million (2017-2022)
  • Table 42. Germany Chronic Diseases Management, by Disease Type USD Million (2017-2022)
  • Table 43. France Chronic Diseases Management, by Application USD Million (2017-2022)
  • Table 44. France Chronic Diseases Management, by Disease Type USD Million (2017-2022)
  • Table 45. Italy Chronic Diseases Management, by Application USD Million (2017-2022)
  • Table 46. Italy Chronic Diseases Management, by Disease Type USD Million (2017-2022)
  • Table 47. United Kingdom Chronic Diseases Management, by Application USD Million (2017-2022)
  • Table 48. United Kingdom Chronic Diseases Management, by Disease Type USD Million (2017-2022)
  • Table 49. Netherlands Chronic Diseases Management, by Application USD Million (2017-2022)
  • Table 50. Netherlands Chronic Diseases Management, by Disease Type USD Million (2017-2022)
  • Table 51. Rest of Europe Chronic Diseases Management, by Application USD Million (2017-2022)
  • Table 52. Rest of Europe Chronic Diseases Management, by Disease Type USD Million (2017-2022)
  • Table 53. MEA Chronic Diseases Management, by Country USD Million (2017-2022)
  • Table 54. MEA Chronic Diseases Management, by Application USD Million (2017-2022)
  • Table 55. MEA Chronic Diseases Management, by Disease Type USD Million (2017-2022)
  • Table 56. Middle East Chronic Diseases Management, by Application USD Million (2017-2022)
  • Table 57. Middle East Chronic Diseases Management, by Disease Type USD Million (2017-2022)
  • Table 58. Africa Chronic Diseases Management, by Application USD Million (2017-2022)
  • Table 59. Africa Chronic Diseases Management, by Disease Type USD Million (2017-2022)
  • Table 60. North America Chronic Diseases Management, by Country USD Million (2017-2022)
  • Table 61. North America Chronic Diseases Management, by Application USD Million (2017-2022)
  • Table 62. North America Chronic Diseases Management, by Disease Type USD Million (2017-2022)
  • Table 63. United States Chronic Diseases Management, by Application USD Million (2017-2022)
  • Table 64. United States Chronic Diseases Management, by Disease Type USD Million (2017-2022)
  • Table 65. Canada Chronic Diseases Management, by Application USD Million (2017-2022)
  • Table 66. Canada Chronic Diseases Management, by Disease Type USD Million (2017-2022)
  • Table 67. Mexico Chronic Diseases Management, by Application USD Million (2017-2022)
  • Table 68. Mexico Chronic Diseases Management, by Disease Type USD Million (2017-2022)
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Company Basic Information, Sales Area and Its Competitors
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Company Basic Information, Sales Area and Its Competitors
  • Table 80. Company Basic Information, Sales Area and Its Competitors
  • Table 81. Company Basic Information, Sales Area and Its Competitors
  • Table 82. Chronic Diseases Management: by Application(USD Million)
  • Table 83. Chronic Diseases Management Ambulatory Care Centers , by Region USD Million (2023-2028)
  • Table 84. Chronic Diseases Management Hospitals and Physician Groups , by Region USD Million (2023-2028)
  • Table 85. Chronic Diseases Management Diagnostic Centers , by Region USD Million (2023-2028)
  • Table 86. Chronic Diseases Management Home Healthcare Agencies and Nursing Homes , by Region USD Million (2023-2028)
  • Table 87. Chronic Diseases Management Others , by Region USD Million (2023-2028)
  • Table 88. Chronic Diseases Management: by Disease Type(USD Million)
  • Table 89. Chronic Diseases Management Arthritis , by Region USD Million (2023-2028)
  • Table 90. Chronic Diseases Management Cardiovascular Disease , by Region USD Million (2023-2028)
  • Table 91. Chronic Diseases Management Cancer , by Region USD Million (2023-2028)
  • Table 92. Chronic Diseases Management Diabetes , by Region USD Million (2023-2028)
  • Table 93. South America Chronic Diseases Management, by Country USD Million (2023-2028)
  • Table 94. South America Chronic Diseases Management, by Application USD Million (2023-2028)
  • Table 95. South America Chronic Diseases Management, by Disease Type USD Million (2023-2028)
  • Table 96. Brazil Chronic Diseases Management, by Application USD Million (2023-2028)
  • Table 97. Brazil Chronic Diseases Management, by Disease Type USD Million (2023-2028)
  • Table 98. Argentina Chronic Diseases Management, by Application USD Million (2023-2028)
  • Table 99. Argentina Chronic Diseases Management, by Disease Type USD Million (2023-2028)
  • Table 100. Rest of South America Chronic Diseases Management, by Application USD Million (2023-2028)
  • Table 101. Rest of South America Chronic Diseases Management, by Disease Type USD Million (2023-2028)
  • Table 102. Asia Pacific Chronic Diseases Management, by Country USD Million (2023-2028)
  • Table 103. Asia Pacific Chronic Diseases Management, by Application USD Million (2023-2028)
  • Table 104. Asia Pacific Chronic Diseases Management, by Disease Type USD Million (2023-2028)
  • Table 105. China Chronic Diseases Management, by Application USD Million (2023-2028)
  • Table 106. China Chronic Diseases Management, by Disease Type USD Million (2023-2028)
  • Table 107. Japan Chronic Diseases Management, by Application USD Million (2023-2028)
  • Table 108. Japan Chronic Diseases Management, by Disease Type USD Million (2023-2028)
  • Table 109. India Chronic Diseases Management, by Application USD Million (2023-2028)
  • Table 110. India Chronic Diseases Management, by Disease Type USD Million (2023-2028)
  • Table 111. South Korea Chronic Diseases Management, by Application USD Million (2023-2028)
  • Table 112. South Korea Chronic Diseases Management, by Disease Type USD Million (2023-2028)
  • Table 113. Taiwan Chronic Diseases Management, by Application USD Million (2023-2028)
  • Table 114. Taiwan Chronic Diseases Management, by Disease Type USD Million (2023-2028)
  • Table 115. Australia Chronic Diseases Management, by Application USD Million (2023-2028)
  • Table 116. Australia Chronic Diseases Management, by Disease Type USD Million (2023-2028)
  • Table 117. Rest of Asia-Pacific Chronic Diseases Management, by Application USD Million (2023-2028)
  • Table 118. Rest of Asia-Pacific Chronic Diseases Management, by Disease Type USD Million (2023-2028)
  • Table 119. Europe Chronic Diseases Management, by Country USD Million (2023-2028)
  • Table 120. Europe Chronic Diseases Management, by Application USD Million (2023-2028)
  • Table 121. Europe Chronic Diseases Management, by Disease Type USD Million (2023-2028)
  • Table 122. Germany Chronic Diseases Management, by Application USD Million (2023-2028)
  • Table 123. Germany Chronic Diseases Management, by Disease Type USD Million (2023-2028)
  • Table 124. France Chronic Diseases Management, by Application USD Million (2023-2028)
  • Table 125. France Chronic Diseases Management, by Disease Type USD Million (2023-2028)
  • Table 126. Italy Chronic Diseases Management, by Application USD Million (2023-2028)
  • Table 127. Italy Chronic Diseases Management, by Disease Type USD Million (2023-2028)
  • Table 128. United Kingdom Chronic Diseases Management, by Application USD Million (2023-2028)
  • Table 129. United Kingdom Chronic Diseases Management, by Disease Type USD Million (2023-2028)
  • Table 130. Netherlands Chronic Diseases Management, by Application USD Million (2023-2028)
  • Table 131. Netherlands Chronic Diseases Management, by Disease Type USD Million (2023-2028)
  • Table 132. Rest of Europe Chronic Diseases Management, by Application USD Million (2023-2028)
  • Table 133. Rest of Europe Chronic Diseases Management, by Disease Type USD Million (2023-2028)
  • Table 134. MEA Chronic Diseases Management, by Country USD Million (2023-2028)
  • Table 135. MEA Chronic Diseases Management, by Application USD Million (2023-2028)
  • Table 136. MEA Chronic Diseases Management, by Disease Type USD Million (2023-2028)
  • Table 137. Middle East Chronic Diseases Management, by Application USD Million (2023-2028)
  • Table 138. Middle East Chronic Diseases Management, by Disease Type USD Million (2023-2028)
  • Table 139. Africa Chronic Diseases Management, by Application USD Million (2023-2028)
  • Table 140. Africa Chronic Diseases Management, by Disease Type USD Million (2023-2028)
  • Table 141. North America Chronic Diseases Management, by Country USD Million (2023-2028)
  • Table 142. North America Chronic Diseases Management, by Application USD Million (2023-2028)
  • Table 143. North America Chronic Diseases Management, by Disease Type USD Million (2023-2028)
  • Table 144. United States Chronic Diseases Management, by Application USD Million (2023-2028)
  • Table 145. United States Chronic Diseases Management, by Disease Type USD Million (2023-2028)
  • Table 146. Canada Chronic Diseases Management, by Application USD Million (2023-2028)
  • Table 147. Canada Chronic Diseases Management, by Disease Type USD Million (2023-2028)
  • Table 148. Mexico Chronic Diseases Management, by Application USD Million (2023-2028)
  • Table 149. Mexico Chronic Diseases Management, by Disease Type USD Million (2023-2028)
  • Table 150. Research Programs/Design for This Report
  • Table 151. Key Data Information from Secondary Sources
  • Table 152. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Chronic Diseases Management: by Application USD Million (2017-2022)
  • Figure 5. Global Chronic Diseases Management: by Disease Type USD Million (2017-2022)
  • Figure 6. South America Chronic Diseases Management Share (%), by Country
  • Figure 7. Asia Pacific Chronic Diseases Management Share (%), by Country
  • Figure 8. Europe Chronic Diseases Management Share (%), by Country
  • Figure 9. MEA Chronic Diseases Management Share (%), by Country
  • Figure 10. North America Chronic Diseases Management Share (%), by Country
  • Figure 11. Global Chronic Diseases Management share by Players 2022 (%)
  • Figure 12. Global Chronic Diseases Management share by Players (Top 3) 2022(%)
  • Figure 13. Global Chronic Diseases Management share by Players (Top 5) 2022(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. TriZetto Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 16. TriZetto Corporation (United States) Revenue: by Geography 2022
  • Figure 17. Phytel Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Phytel Inc. (United States) Revenue: by Geography 2022
  • Figure 19. Pegasystems Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 20. Pegasystems Inc. (United States) Revenue: by Geography 2022
  • Figure 21. Siemens Healthcare Private Limited (India) Revenue, Net Income and Gross profit
  • Figure 22. Siemens Healthcare Private Limited (India) Revenue: by Geography 2022
  • Figure 23. AxisPoint Health (United States) Revenue, Net Income and Gross profit
  • Figure 24. AxisPoint Health (United States) Revenue: by Geography 2022
  • Figure 25. Wellcentive, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Wellcentive, Inc. (United States) Revenue: by Geography 2022
  • Figure 27. Medecision, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Medecision, Inc. (United States) Revenue: by Geography 2022
  • Figure 29. I2i Systems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 30. I2i Systems, Inc. (United States) Revenue: by Geography 2022
  • Figure 31. HealthSmart Holdings, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. HealthSmart Holdings, Inc. (United States) Revenue: by Geography 2022
  • Figure 33. Allscripts Healthcare Solutions, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. Allscripts Healthcare Solutions, Inc. (United States) Revenue: by Geography 2022
  • Figure 35. Epic Corporation Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Epic Corporation Inc. (United States) Revenue: by Geography 2022
  • Figure 37. Harmony Information Systems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 38. Harmony Information Systems, Inc. (United States) Revenue: by Geography 2022
  • Figure 39. Infosys Limited (India) Revenue, Net Income and Gross profit
  • Figure 40. Infosys Limited (India) Revenue: by Geography 2022
  • Figure 41. Global Chronic Diseases Management: by Application USD Million (2023-2028)
  • Figure 42. Global Chronic Diseases Management: by Disease Type USD Million (2023-2028)
  • Figure 43. South America Chronic Diseases Management Share (%), by Country
  • Figure 44. Asia Pacific Chronic Diseases Management Share (%), by Country
  • Figure 45. Europe Chronic Diseases Management Share (%), by Country
  • Figure 46. MEA Chronic Diseases Management Share (%), by Country
  • Figure 47. North America Chronic Diseases Management Share (%), by Country
List of companies from research coverage that are profiled in the study
  • TriZetto Corporation (United States)
  • Phytel Inc. (United States)
  • Pegasystems Inc. (United States)
  • Siemens Healthcare Private Limited (India)
  • AxisPoint Health (United States)
  • Wellcentive, Inc. (United States)
  • Medecision, Inc. (United States)
  • i2i Systems, Inc. (United States)
  • HealthSmart Holdings, Inc. (United States)
  • Allscripts Healthcare Solutions, Inc. (United States)
  • Epic Corporation Inc. (United States)
  • Harmony Information Systems, Inc. (United States)
  • Infosys Limited (India)
Additional players considered in the study are as follows:
ScienceSoft USA Corporation (United States) , MINES & Associates (United States) , ZeOmega Inc. (United States)
Select User Access Type

Key Highlights of Report


May 2023 239 Pages 67 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Chronic Diseases Management Market Quantitative research analysis
Global Chronic Diseases Management Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2018-2022; Base year: 2022; Forecast period: 2022 to 2028
Companies that are profiled in Global Chronic Diseases Management Market are TriZetto Corporation (United States), Phytel Inc. (United States), Pegasystems Inc. (United States), Siemens Healthcare Private Limited (India), AxisPoint Health (United States), Wellcentive, Inc. (United States), Medecision, Inc. (United States), i2i Systems, Inc. (United States), HealthSmart Holdings, Inc. (United States), Allscripts Healthcare Solutions, Inc. (United States), Epic Corporation Inc. (United States), Harmony Information Systems, Inc. (United States) and Infosys Limited (India) etc.
Ambulatory Care Centers segment in Global market to hold robust market share owing to "Growing incidence of chronic diseases ".
AMA Research predicts that United States Players will contribute to the maximum growth of Global Chronic Diseases Management market throughout the forecasted period.

Know More About Global Chronic Diseases Management Market Report?

Have a Query? Click Here

Other Related Reports

Salmonella Testing Comprehensive Study by Type (Molecular Diagnostics, Monoclonal Antibodies, Immunoassays, Differential Light Scattering), Application (Hospitals, Public Health Labs, Physician Offic...
$ 3350
Facial Aesthetics Comprehensive Study by Type (Dermal Fillers, Botulinum Toxin, Chemical Peel, Microdermabrasion, Hyaluronic acid), Application (Facial Line Correction Treatment, Scar Treatment, Lip ...
$ 3650
Basal Cell Carcinoma Treatment Comprehensive Study by Application (Hospitals, Specialty Clinics, Others), Stages (Stage 0, Stage 1, Stage 2, Stage 3, Stage 4), Treatment Type (Surgery {Surgical Excis...
$ 3750
Pulmonary Drug Delivery Systems Comprehensive Study by Type (Metered Dose Inhalers (Manually-Actuated Pressurized Inhaler, Breath-Actuated Pressurized Inhaler), Dry Powder Inhalers (Single-Dose Inhal...
$ 3750
Blood Culture Test Comprehensive Study by Type (Consumables (Bacterial Infections, Fungal Infections, Mycobacterial Infections, Blood Culture Media, Assay, Kits, and Reagents, Blood Culture Accessori...
$ 3750
Syphilis Testing Comprehensive Study by Type (Treponemal tests, Non-treponemal tests), Syphilis types (Primary Syphilis, Secondary Syphilis, Others (Latent (hidden) stage, Tertiary (late) stage)), G...
$ 3450